BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Damiris K, Tafesh ZH, Pyrsopoulos N. Efficacy and safety of anti-hepatic fibrosis drugs. World J Gastroenterol 2020; 26(41): 6304-6321 [PMID: 33244194 DOI: 10.3748/wjg.v26.i41.6304]
URL: https://www.wjgnet.com/1007-9327/full/v26/i41/6304.htm
Number Citing Articles
1
Arshi Khanam, Paul G. Saleeb, Shyam Kottilil. Pathophysiology and Treatment Options for Hepatic Fibrosis: Can It Be Completely Cured?Cells 2021; 10(5): 1097 doi: 10.3390/cells10051097
2
Kehuan Yin, Xuedong Li, Xiaomin Luo, Yuru Sha, Puyang Gong, Jian Gu, Rui Tan, Rômulo Dias Novaes. Hepatoprotective Effect and Potential Mechanism of Aqueous Extract from Phyllanthus emblica on Carbon-Tetrachloride-Induced Liver Fibrosis in RatsEvidence-Based Complementary and Alternative Medicine 2021; 2021: 1 doi: 10.1155/2021/5345821
3
Asma Ahrari, Hossein Najafzadehvarzi, Ali Taravati, Fatemeh Tohidi. The inhibitory effect of PLGA-encapsulated berberine on hepatotoxicity and α-smooth muscle actin (α-SMA) gene expressionLife Sciences 2021; 284: 119884 doi: 10.1016/j.lfs.2021.119884
4
Yan Xue, Meng Zhang, Tao Li, Feng Liu, Li-Xin Zhang, Xiao-Ping Fan, Bao-Hua Yang, Lei Wang. Exploration of nucleos(t)ide analogs cessation in chronic hepatitis B patients with hepatitis B e antigen lossWorld Journal of Gastroenterology 2021; 27(14): 1497-1506 doi: 10.3748/wjg.v27.i14.1497
5
Paula Sánchez Sánchez, María del Mar Rigual, Nabil Djouder. Inflammatory and Non-Inflammatory Mechanisms Controlling Cirrhosis DevelopmentCancers 2021; 13(20): 5045 doi: 10.3390/cancers13205045
6
Xia Niu, Xiaomei Wang, Bingyu Niu, Yanan Meng, Hongwei He, Yucheng Wang, Guiling Li. Costunolide Loaded in pH-Responsive Mesoporous Silica Nanoparticles for Increased Stability and an Enhanced Anti-Fibrotic EffectPharmaceuticals 2021; 14(10): 951 doi: 10.3390/ph14100951
7
Xia Niu, Xiaomei Wang, Bingyu Niu, Guoqing Li, Xinyi Yang, Yucheng Wang, Guiling Li. Novel IMB16-4 Compound Loaded into Silica Nanoparticles Exhibits Enhanced Oral Bioavailability and Increased Anti-Liver Fibrosis In VitroMolecules 2021; 26(6): 1545 doi: 10.3390/molecules26061545
8
Qiaoting Hu, Mingyu Liu, Yundan You, Guo Zhou, Ye Chen, Hui Yuan, Lulu Xie, Shisong Han, Kangshun Zhu. Dual inhibition of reactive oxygen species and spleen tyrosine kinase as a therapeutic strategy in liver fibrosisFree Radical Biology and Medicine 2021; 175: 193 doi: 10.1016/j.freeradbiomed.2021.08.241